| Idaho Prosthetics & Orthotics, Inc | |
| 333 N 18th Ave, Ste B4, Pocatello, Idaho 83201 | |
| (208) 478-8800 |
| Name | Idaho Prosthetics & Orthotics, Inc |
|---|---|
| Organization Name | Idaho Prosthetics & Orthotics, Inc. |
| Location | 333 N 18th Ave, Ste B4, Pocatello, Idaho 83201 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (208) 478-8800 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
One in six countries is expected to have substantially high out-of-pocket spending as a proportion of total health expenditures by 2050, according to a new scientific study.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has been featured in an in-depth report by Griffin Securities, a New York-based brokerage firm, highlighting the importance of the role that cancer stem cell (CSCs) targeting technology such as that employed by its lead product candidate, ICT-121, may play in developing future cancer treatments.
Researchers from the University's Warwick Medical School have found many healthcare professionals are failing to tell patients with certain conditions such as diabetes or visual impairment if they are not fit to drive.
Scientists from UCLA and the Howard Hughes Medical Institute successfully used a gene that suppresses cholesterol levels as part of a treatment to reduce plaque in mice with a disorder called familial hypercholesterolemia.
› Verified 6 days ago
| NPI Number | 1952433971 |
| Organization Name | IDAHO PROSTHETICS & ORTHOTICS, INC. |
| Type | Prosthetic/Orthotic Supplier |
| Address | 333 N 18th Ave Ste B4, Pocatello, ID 83201 |
| Phone Number | 208-478-8000 |
News Archive
One in six countries is expected to have substantially high out-of-pocket spending as a proportion of total health expenditures by 2050, according to a new scientific study.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has been featured in an in-depth report by Griffin Securities, a New York-based brokerage firm, highlighting the importance of the role that cancer stem cell (CSCs) targeting technology such as that employed by its lead product candidate, ICT-121, may play in developing future cancer treatments.
Researchers from the University's Warwick Medical School have found many healthcare professionals are failing to tell patients with certain conditions such as diabetes or visual impairment if they are not fit to drive.
Scientists from UCLA and the Howard Hughes Medical Institute successfully used a gene that suppresses cholesterol levels as part of a treatment to reduce plaque in mice with a disorder called familial hypercholesterolemia.
› Verified 6 days ago
News Archive
One in six countries is expected to have substantially high out-of-pocket spending as a proportion of total health expenditures by 2050, according to a new scientific study.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has been featured in an in-depth report by Griffin Securities, a New York-based brokerage firm, highlighting the importance of the role that cancer stem cell (CSCs) targeting technology such as that employed by its lead product candidate, ICT-121, may play in developing future cancer treatments.
Researchers from the University's Warwick Medical School have found many healthcare professionals are failing to tell patients with certain conditions such as diabetes or visual impairment if they are not fit to drive.
Scientists from UCLA and the Howard Hughes Medical Institute successfully used a gene that suppresses cholesterol levels as part of a treatment to reduce plaque in mice with a disorder called familial hypercholesterolemia.
› Verified 6 days ago
Maag Prescription Center Llc Type: Long Term Care Pharmacy Location: 333 W Center St, Pocatello, Idaho 83204 Phone: (208) 233-2063 | |
Snake River Long Term Care Pharmacy Type: Long Term Care Pharmacy Location: 1465 Bannock Hwy, Pocatello, Idaho 83204 Phone: (208) 233-2444 | |
Pharmacy Shop Inc Type: Pharmacy Location: 1015 E Young St, Pocatello, Idaho 83201 Phone: (208) 232-0049 | |
Shaver Holding Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: 235 S 4th Ave, Pocatello, Idaho 83201 Phone: (208) 233-3341 | |
Walgreens #6380 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 905 Yellowstone Ave, Pocatello, Idaho 83201 Phone: (208) 233-2382 |